174 related articles for article (PubMed ID: 17507884)
1. Magnetic Resonance evaluation of disease activity in Graves' ophthalmopathy: T2-time and signal intensity of extraocular muscles.
Majos A; Pajak M; Grzelak P; Stefańczyk L
Med Sci Monit; 2007 May; 13 Suppl 1():44-8. PubMed ID: 17507884
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity.
Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L
Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678
[TBL] [Abstract][Full Text] [Related]
3. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
Rodríguez-González N; Pérez-Rico C; López-Para Giménez R; Arévalo-Serrano J; Del Amo García B; Calzada Domingo L; Flores Ruiz L; Blanco R
Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.
Chen Y; Jin ZY; Zhang ZH; Xu DD; Meng W; Jiang B; Fang HY; Sun ZY; Chen Y; Sun HY; Feng F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):461-7. PubMed ID: 23134821
[TBL] [Abstract][Full Text] [Related]
5. [Graves'ophthalmopathy: usefulness of T2 weighted muscle signal intensity].
Sillaire I; Ravel A; Dalens H; Garcier JM; Boyer L
J Radiol; 2003 Feb; 84(2 Pt 1):139-42. PubMed ID: 12717285
[TBL] [Abstract][Full Text] [Related]
6. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
[TBL] [Abstract][Full Text] [Related]
7. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
8. [Management of Graves' ophthalmopathy by using orbital magnetic resonance imaging].
Hiromatsu Y; Eguchi H; Tani J
Nihon Rinsho; 2012 Nov; 70(11):1932-7. PubMed ID: 23214064
[TBL] [Abstract][Full Text] [Related]
9. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
Szucs-Farkas Z; Toth J; Balazs E; Galuska L; Burman KD; Karanyi Z; Leovey A; Nagy EV
AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
[TBL] [Abstract][Full Text] [Related]
10. Correlation Between Optical Coherence Tomography and Magnetic Resonance Imaging of Rectus Muscle Thickness Measurements in Graves' Ophthalmopathy.
De-Pablo-Gómez-de-Liaño L; Fernández-Vigo JI; Merino-Menéndez S; Duque-Muñoz M; Gómez-de-Liaño R
J Pediatr Ophthalmol Strabismus; 2019 Sep; 56(5):319-326. PubMed ID: 31545866
[TBL] [Abstract][Full Text] [Related]
11. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
[TBL] [Abstract][Full Text] [Related]
12. Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.
Hou K; Ai T; Hu WK; Luo B; Wu YP; Liu R
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):938-942. PubMed ID: 29270757
[TBL] [Abstract][Full Text] [Related]
13. Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves' Ophthalmopathy.
Liu X; Su Y; Jiang M; Fang S; Huang Y; Li Y; Zhong S; Wang Y; Zhang S; Wu Y; Sun J; Fan X; Zhou H
Endocr Pract; 2021 Mar; 27(3):198-205. PubMed ID: 33658136
[TBL] [Abstract][Full Text] [Related]
14. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].
Wu T; Tang DR; Wang F; Xia S; Sun FY
Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264
[No Abstract] [Full Text] [Related]
15. [Results of nuclear magnetic resonance tomography studies in endocrine orbitopathy].
Pedrosa P; Pfannenstiel P; Just M; Higer HP; Utech C; Brederhoff J; Wulle KG
Klin Monbl Augenheilkd; 1988 Aug; 193(2):169-73. PubMed ID: 3184751
[TBL] [Abstract][Full Text] [Related]
16. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.
Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K
Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of extraocular muscles in Graves' ophthalmopathy using T1 mapping.
Zhu H; Zou M; Wu D; Li B; Su Y; Li Y; Hong S; Yang Z
Eur Radiol; 2023 Dec; 33(12):9074-9083. PubMed ID: 37466707
[TBL] [Abstract][Full Text] [Related]
19. Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy.
Li Z; Luo Y; Feng X; Zhang Q; Zhong Q; Weng C; Chen Z; Shen J
J Magn Reson Imaging; 2023 Oct; 58(4):1279-1289. PubMed ID: 36780178
[TBL] [Abstract][Full Text] [Related]
20. Graves ophthalmopathy: MR imaging of the orbits.
Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
